However, insulin treatment may contribute to the multidrug burden of care for people with CF and, our clinical experience has been that, in many cases, multiple daily injection (MDI) regimens may not be optimal for the management of the multifactorial complexity of CFRD. This evidence concerns the gene INS and cystic fibrosis.